395 studies found for:    Chlormethine
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
Conditions: Healthy;   Chronic Kidney Disease
Interventions: Drug: AcSDKP-NH2 inuline;   Drug: AcSDKP-NH2 Cr-EDTA
2 Completed
Has Results
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
Condition: Mycosis Fungoides
Intervention: Drug: mechlorethamine-MCH (nitrogen mustard)
3 Recruiting Observational US Study Assessing Outcomes, Treatment Patterns, AEs, QOL in MF-CTCL Patients and Treated With Valchlor
Condition: Mycosis Fungoides
Intervention: Drug: Valchlor
4 Completed An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
Condition: Mycosis Fungoides
Intervention: Drug: 0.04% Mechlorethamine gel
5 Completed Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: MOPP Regimen;   Drug: Leucovorin Calcium;   Drug: Mechlorethamine Hydrochloride;   Drug: Methotrexate;   Drug: Prednisone;   Drug: Procarbazine Hydrochloride;   Drug: Vincristine Sulfate;   Procedure: Conventional Surgery
6 Recruiting Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Yellow Mustard Gum Fibre;   Other: Soluble Flaxseed Gum Fibre;   Other: Fenugreek Gum Fibre
7 Completed Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
Condition: Bronchiolitis
Intervention: Drug: furosemide
8 Completed Experimental Denture Pastes
Conditions: Dental Plaque;   Denture Stomatitis;   Oral Candidiasis;   Oral Hygiene
Intervention: Other: Dentifrice
9 Completed Examination of the Effects of Four Different Spices on Energy Metabolism
Condition: Healthy
Interventions: Dietary Supplement: ginger;   Dietary Supplement: black pepper;   Dietary Supplement: horseradish;   Dietary Supplement: mustard;   Dietary Supplement: placebo
10 Recruiting Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL);   Leukemia, Myeloid, Acute(AML);   Leukemia, Myeloid, Chronic(CML);   Juvenile Myelomonocytic Leukemia (JMML);   Hemoglobinuria, Paroxysmal Nocturnal (PNH);   Hodgkin Lymphoma;   Lymphoma, Non-Hodgkin (NHL);   Myelodysplastic Syndrome (MDS)
Interventions: Device: CliniMACS;   Procedure: Stem cell transplantation;   Drug: Fludarabine;   Drug: Thioplex®;   Drug: L-phenylalanine mustard;   Drug: Mycophenolate mofetil;   Drug: Rituxan™;   Drug: Alemtuzumab;   Drug: Cyclophosphamide;   Drug: Anti-thymocyte globulin (Rabbit);   Drug: G-CSF
11 Completed Helium:Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard
Conditions: Bronchiolitis;   Chronic Bronchitis
Intervention: Drug: helium:oxygen mixture
12 Active, not recruiting Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
Condition: Hodgkin's Lymphoma
Interventions: Drug: Adriamycin, Vinblastine, Vincristine, Bleomycin, Etoposide, Nitrogen Mustard (Cyclophosphamide), Prednisone;   Procedure: Radiotherapy;   Drug: Etoposide, Nitrogen Mustard (Cyclophosphamide) , Vincristine, Vinblastine, Adriamycin, Bleomycin, Prednisone
13 Recruiting Impact of Sunflower Seed Oil Massage on Neonatal Mortality and Morbidity in Nepal
Conditions: Neonatal Mortality;   Neonatal Sepsis
Interventions: Other: Sunflower seed oil;   Other: Mustard seed oil
14 Enrolling by invitation Psychophysiological Effects of Thorax Wraps With Ginger and Mustard Flour
Condition: Healthy
Interventions: Drug: Zingiberis Rhizoma plv.;   Drug: Sinapis nigrea semen;   Drug: Placebo
15 Completed Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma Patients
Condition: Hodgkin's Lymphoma
Intervention: Drug: ITF2357
16 Active, not recruiting Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1;   Untreated Adult Acute Lymphoblastic Leukemia
Interventions: Biological: Alemtuzumab;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dasatinib;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Etoposide Phosphate;   Biological: Filgrastim;   Drug: Fludarabine Phosphate;   Procedure: In Vitro-Treated Peripheral Blood Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Melphalan;   Drug: Mercaptopurine;   Drug: Methotrexate;   Biological: Pegfilgrastim;   Other: Pharmacological Study;   Drug: Tacrolimus;   Drug: Vincristine Sulfate
17 Not yet recruiting Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Conditions: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma;   Recurrent Diffuse Large B-Cell Lymphoma;   Refractory Diffuse Large B-Cell Lymphoma
Interventions: Procedure: Autologous Bone Marrow Transplantation;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Carmustine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Ibrutinib;   Other: Laboratory Biomarker Analysis;   Drug: Melphalan;   Other: Placebo
18 Active, not recruiting Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
Condition: Refractory Plasma Cell Myeloma
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Bortezomib;   Drug: Cyclosporine;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Melphalan;   Drug: Mycophenolate Mofetil;   Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation;   Procedure: Peripheral Blood Stem Cell Transplantation;   Procedure: Syngeneic Bone Marrow Transplantation;   Radiation: Total-Body Irradiation
19 Active, not recruiting Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Conditions: Localized Resectable Neuroblastoma;   Localized Unresectable Neuroblastoma;   Recurrent Neuroblastoma;   Regional Neuroblastoma;   Stage 4 Neuroblastoma;   Stage 4S Neuroblastoma
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Radiation: External Beam Radiation Therapy;   Biological: Filgrastim;   Drug: Isotretinoin;   Other: Laboratory Biomarker Analysis;   Drug: Melphalan;   Procedure: Peripheral Blood Stem Cell Transplantation;   Other: Pharmacological Study;   Drug: Thiotepa;   Drug: Topotecan Hydrochloride;   Drug: Vincristine Sulfate Liposome
20 Completed A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer
Condition: Advanced Cancer
Intervention: Drug: ZIO-201

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years